Whittier Trust’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
PAI
6CM
Whittier Trust's ANAB Position: Q1 2026 in Review
Whittier Trust sold out of AnaptysBio (ANAB) in Q1 2026, closing a stake of 224 shares — an estimated $9.84K sold.
Whittier Trust first reported a position in ANAB in Q2 2019 and held it in 23 quarters. The position peaked at $213K in Q2 2019. 208 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.
- Whittier Trust reported no remaining AnaptysBio position as of Q1 2026 after selling out during the quarter.
- Whittier Trust sold 224 AnaptysBio shares in Q1 2026, an estimated $9.84K.
- Whittier Trust first reported a position in AnaptysBio in Q2 2019 and held it in 23 quarters.
- Whittier Trust's AnaptysBio position peaked at $213K in Q2 2019.
- 208 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.
Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.